Beta-Hydroxybutyrate Feasibility Treating IBS
Conditions: Crohn ' s Disease; Irritable Bowel Syndrome Interventions: Biological: Feasibility of beta-hydroxybutyrate supplementation to reduce inflammation in patients with Inflammatory Bowel Disease Sponsors: University of Texas at Austin Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Crohn's Disease | Inflammatory Bowel Disease | Irritable Bowel Syndrome | Research | Texas University